Marina Rubio

1.8k total citations
41 papers, 1.3k citations indexed

About

Marina Rubio is a scholar working on Epidemiology, Neurology and Pharmacology. According to data from OpenAlex, Marina Rubio has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 13 papers in Neurology and 11 papers in Pharmacology. Recurrent topics in Marina Rubio's work include Neuroinflammation and Neurodegeneration Mechanisms (11 papers), Cannabis and Cannabinoid Research (11 papers) and Acute Ischemic Stroke Management (11 papers). Marina Rubio is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (11 papers), Cannabis and Cannabinoid Research (11 papers) and Acute Ischemic Stroke Management (11 papers). Marina Rubio collaborates with scholars based in France, Spain and Italy. Marina Rubio's co-authors include Denis Vivien, María‐Paz Viveros, Damien Levard, Carmen Guaza, Eva M. Marco, Antoine Drieu, Javier Fernández‐Ruíz, Emilio Ambrosio, Carine Ali and Izaskun Buendía and has published in prestigious journals such as Nature Communications, Blood and Nature Neuroscience.

In The Last Decade

Marina Rubio

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marina Rubio France 22 490 447 282 263 202 41 1.3k
Laura Latini Italy 15 259 0.5× 252 0.6× 156 0.6× 191 0.7× 151 0.7× 19 737
Jane P. Hughes United Kingdom 13 242 0.5× 559 1.3× 302 1.1× 586 2.2× 62 0.3× 20 2.1k
Yujiao Lu United States 19 143 0.3× 262 0.6× 358 1.3× 396 1.5× 86 0.4× 28 1.5k
Elisa Bisicchia Italy 15 159 0.3× 185 0.4× 173 0.6× 241 0.9× 142 0.7× 23 835
Nan Gu China 17 112 0.2× 415 0.9× 377 1.3× 375 1.4× 109 0.5× 37 1.4k
Ohannes K. Melemedjian United States 24 201 0.4× 631 1.4× 106 0.4× 703 2.7× 74 0.4× 35 2.0k
Kazuhiko Nakadate Japan 18 118 0.2× 589 1.3× 203 0.7× 594 2.3× 128 0.6× 66 1.4k
Bao‐Chun Jiang China 24 183 0.4× 660 1.5× 336 1.2× 622 2.4× 64 0.3× 49 2.1k
Takahiro Shimizu Japan 23 146 0.3× 252 0.6× 169 0.6× 414 1.6× 103 0.5× 134 1.7k
Magdalena Żychowska Poland 18 182 0.4× 398 0.9× 130 0.5× 168 0.6× 91 0.5× 67 1.4k

Countries citing papers authored by Marina Rubio

Since Specialization
Citations

This map shows the geographic impact of Marina Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Rubio more than expected).

Fields of papers citing papers by Marina Rubio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Rubio. The network helps show where Marina Rubio may publish in the future.

Co-authorship network of co-authors of Marina Rubio

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Rubio. A scholar is included among the top collaborators of Marina Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Rubio. Marina Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levard, Damien, Eloïse Lemarchand, Flavie Lesept, et al.. (2024). Improving stroke outcomes in hyperglycemic mice by modulating tPA/NMDAR signaling to reduce inflammation and hemorrhages. Blood Advances. 8(5). 1330–1344. 4 indexed citations
2.
Rubio, Marina, et al.. (2024). Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity. Biology Direct. 19(1). 26–26. 6 indexed citations
3.
Correa‐Paz, Clara, María Pérez‐Mato, Issan Zhang, et al.. (2024). Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke. Journal of Nanobiotechnology. 22(1). 10–10. 10 indexed citations
4.
Levard, Damien, Antoine Fournier, Eloïse Lemarchand, et al.. (2024). Central nervous system-associated macrophages modulate the immune response following stroke in aged mice. Nature Neuroscience. 27(9). 1721–1733. 22 indexed citations
5.
Levard, Damien, Carine Ali, Izaskun Buendía, et al.. (2021). Factor XII protects neurons from apoptosis by epidermal and hepatocyte growth factor receptor‐dependent mechanisms. Journal of Thrombosis and Haemostasis. 19(9). 2235–2247. 4 indexed citations
6.
Levard, Damien, et al.. (2020). Filling the gaps on stroke research: Focus on inflammation and immunity. Brain Behavior and Immunity. 91. 649–667. 74 indexed citations
7.
Drieu, Antoine, Damien Levard, Francisco Campos, et al.. (2020). Alcohol exposure–induced neurovascular inflammatory priming impacts ischemic stroke and is linked with brain perivascular macrophages. JCI Insight. 5(4). 25 indexed citations
8.
Anfray, Antoine, Antoine Drieu, Vincent Hingot, et al.. (2019). Circulating tPA contributes to neurovascular coupling by a mechanism involving the endothelial NMDA receptors. Journal of Cerebral Blood Flow & Metabolism. 40(10). 2038–2054. 29 indexed citations
9.
Drieu, Antoine, et al.. (2019). Immune Responses and Anti-inflammatory Strategies in a Clinically Relevant Model of Thromboembolic Ischemic Stroke with Reperfusion. Translational Stroke Research. 11(3). 481–495. 33 indexed citations
10.
Vézain, Myriam, Marina Rubio, Valérie Dupé, et al.. (2018). A de novo variant in ADGRL2 suggests a novel mechanism underlying the previously undescribed association of extreme microcephaly with severely reduced sulcation and rhombencephalosynapsis. Acta Neuropathologica Communications. 6(1). 109–109. 16 indexed citations
11.
Rubio, Marina, Fabián Docagne, Benoit D. Roussel, et al.. (2011). Pharmacological Activation/Inhibition of the Cannabinoid System Affects Alcohol Withdrawal-Induced Neuronal Hypersensitivity to Excitotoxic Insults. PLoS ONE. 6(8). e23690–e23690. 20 indexed citations
12.
Lemarchant, Sighild, Fabián Docagne, Évelyne Emery, et al.. (2011). tPA in the injured central nervous system: different scenarios starring the same actor?. Neuropharmacology. 62(2). 749–756. 40 indexed citations
13.
Rubio, Marina, Rosario de Miguel, Javier Fernández‐Ruíz, et al.. (2008). Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas. Drug and Alcohol Dependence. 99(1-3). 354–358. 31 indexed citations
14.
Miyamoto, Shingo, Marina Rubio, & Mark A. Sussman. (2008). Nuclear and mitochondrial signalling Akts in cardiomyocytes. Cardiovascular Research. 82(2). 272–285. 51 indexed citations
15.
Rubio, Marina, Douglas McHugh, Javier Fernández‐Ruíz, Heather B. Bradshaw, & James M. Walker. (2007). Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. Neuroscience Letters. 421(3). 270–274. 58 indexed citations
16.
Colombo, Giancarlo, Alessandro Orrù, P. Lai, et al.. (2007). The Cannabinoid CB1 Receptor Antagonist, Rimonabant, as a Promising Pharmacotherapy for Alcohol Dependence: Preclinical Evidence. Molecular Neurobiology. 36(1). 102–112. 40 indexed citations
17.
Valenti, Marta, Erika Cottone, Rosario Martínez, et al.. (2005). The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake. Journal of Neurochemistry. 95(3). 662–672. 67 indexed citations
18.
Marco, Eva M., Érika Borcel, Marina Rubio, et al.. (2004). Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats. Behavioural Pharmacology. 15(1). 21–27. 112 indexed citations
19.
Borcel, Érika, Marı́a L. de Ceballos, Eva M. Marco, et al.. (2004). Functional responses to the cannabinoid agonist WIN 55,212-2 in neonatal rats of both genders: influence of weaning. Pharmacology Biochemistry and Behavior. 78(3). 593–602. 16 indexed citations
20.
Martín‐Fernández, Beatriz, Eva M. Marco, Marina Rubio, et al.. (2003). Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood. Psychopharmacology. 170(3). 301–308. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026